Please note, this OEL/ADE monograph also applies to sitagliptin phosphate (CAS RN 654671-78-0), sitagliiptin phosphate monohydrate (CAS RN 654671-77-9), sitagliptin hydrochloride (CAS RN 486459-71-6), sitagliptin malate (CAS RN 1240039-02-4), sitagliptin sulphate (CAS RN 1169707-31-6), and the alternate salt (CAS RN 862156-92-1). Sitagliptin phosphate is used in conjunction with diet and exercise to control blood glucose concentration in adults with type II diabetes. Sitagliptin phosphate is thought to act by prolonging increased incretin levels which indirectly improves glucose level stability and lowers elevated blood glucose concentrations.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Sitagliptin, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.